Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
The inducible T cell co‐stimulator (ICOS) is expressed on activated CD4⁺ T cells and is critical for germinal center formation, Ig class switching, and T follicular helper cell support. Autosomal recessive ICOS deficiency causes a monogenic form of common variable immunodeficiency (Common Variable Immunodeficiency; CVID) characterised by profound hypogammaglobulinemia, recurrent bacterial infections, enteropathy, and lymphoproliferation.
Genetic evidence supports a definitive gene–disease relationship. Homozygous ICOS deletions and frameshift, splice‐site, and missense loss‐of‐function variants have been identified in over 30 probands from at least 12 unrelated families ([PMID:16384931], [PMID:26399252], [PMID:31858365]), including a recurrent founder deletion NM_012092.4(ICOS):c.59-594_501+93del ([PMID:15507387]). Segregation analysis in autosomal recessive families demonstrated complete cosegregation of biallelic ICOS variants with CVID phenotype in 5 affected relatives across multiple pedigrees ([PMID:15507387]).
Variant spectrum encompasses large genomic deletions, frameshifts, canonical splice‐site mutations, and missense changes. A representative missense allele is c.356T>C (p.Phe119Ser) ([PMID:31858365]), which abolishes ICOS surface expression and impairs T follicular helper cell differentiation. Most variants lead to truncated proteins or absent transcripts, consistent with a loss‐of‐function mechanism.
Functional studies are concordant with clinical findings. ICOS‐deficient patients exhibit absent germinal centers, severely reduced class‐switched memory B cells, and diminished circulating CXCR5⁺ T follicular helper cells, with impaired IL-10, IL-17 and enhanced IL-12 responses. Murine models and in vitro rescue experiments confirm that ICOS loss disrupts T–B cell collaboration and immunoglobulin production ([PMID:16384931], [PMID:31858365]).
No credible studies dispute the association; no pathogenic ICOS variants have been found in large CVID cohorts without corresponding functional deficits. The mechanistic and genetic concordance across diverse populations meets ClinGen criteria for a definitive classification.
Key Take-home: ICOS deficiency is a monogenic autosomal recessive cause of CVID, with clear diagnostic markers (biallelic LOF variants and absent ICOS expression) and therapeutic implications for immunoglobulin replacement and tailored immunomodulation.
Gene–Disease AssociationDefinitiveMonogenic ICOS deficiency identified in >30 probands across >12 unrelated families with segregation and consistent functional data Genetic EvidenceStrongAutosomal recessive inheritance with biallelic LOF variants in >30 probands, including founder deletion and multiple families Functional EvidenceStrongConcordant patient immunophenotyping, germinal center defects, cytokine dysregulation, murine and in vitro rescue models |